LNA Sante SA

LNA Sante SA

23.60
EUR
-0.10
(-0.42%)
251.29MMarket Cap
Mar 31Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
38.24
41.8
48.18
52.66
50.28
55.74
54.7
59.89
71.98
70.3
72.01
78.89
88.96
- -
Basic EPS, GAAP
0.91
0.83
1.2
2.4
2.5
2.23
2.16
0.81
2.45
2.49
2.29
2.13
2.35
- -
Free Cash Flow per Basic Share
1.93
-0.16
1.01
2.52
5.51
3.98
11.55
13.85
6.89
8.67
8.27
9.61
8.42
- -
Dividend per Share
- -
- -
- -
0.16
0.23
0.32
0.38
0.45
0.2
0.44
0.5
0.6
0.65
- -
Book Value per Share
10.84
11.72
13.22
16.29
18.67
20.41
19.62
19.72
22.45
27.73
29.27
30.69
32.2
32.2
Tangible Book Value per Share
-17.69
-21.98
-20.82
-15.38
-13.26
-13.43
-18.13
-36.57
-34.35
-26.21
-25.7
-25.89
-24.05
-24.05
Basic Weighted Avg Shares
8
9
9
9
10
10
10
10
10
10
10
10
10
10
Sales/Revenue/Turnover
324
356
425
475
487
539
528
574
689
728
736
807
913
- -
Operating Margin (%)
7.11
6.9
8.08
7.63
8.35
7.81
10.27
8.21
8.54
8.82
8.61
8.34
8.21
- -
Depreciation Expense
11
19
11
11
11
10
56
70
81
84
80
89
83
- -
Net Income, GAAP
8
7
11
22
24
22
21
8
24
26
23
22
24
- -
Effective Tax Rate (%)
41.83
27.74
48.37
14.56
19.26
37.16
40.5
54.74
40.23
36.86
34.9
32.31
35.3
- -
Profit Margin (%)
2.38
1.97
2.5
4.55
4.98
4
3.95
1.36
3.41
3.54
3.18
2.7
2.65
- -
Working Capital
-13
-21
-3
37
42
25
-12
-256
-195
-178
-20
-38
-39
-39
LT Debt
89
111
177
189
187
171
626
641
661
616
742
696
684
684
Total Equity
93
105
124
164
188
204
197
196
223
299
309
324
341
341
Return on Invested Capital (%)
4.62
5.17
4.07
6.27
6.04
4.94
4.18
1.52
2.76
3.27
3.38
3.51
3.6
- -
Return on Capital (%)
5.04
4.42
3.72
5.88
5.68
4.7
4
1.48
2.92
3
3.35
3.39
3.42
- -
Return on Common Equity (%)
8.68
7.31
9.74
15.67
14.31
11.4
10.78
4.13
11.62
10.21
7.95
7.12
7.5
- -

Capital Structure

EUR

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
180
186
223
LT Borrowings
315
318
296
LT Finance Leases
381
398
388
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
246
256
251

Working Capital

EUR

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
374
389
421
Cash, Cash Equivalents & STI
75
68
95
Accounts Receivable, Net
76
89
83
Inventories
179
195
198
Total Current Liabilities
412
423
461
Payables & Accruals
- -
- -
- -
ST Debt
180
186
223
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.32%
12.3%
5.54%
Free Cash Flow
45.47%
-3.17%
-12.1%
Net Income, GAAP
24.42%
41.1%
10.68%
Sales/Revenue/Turnover
8.12%
9.91%
13.15%
Total Cash Common Dividend
- -
24.44%
8.72%

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
736
2024
- -
- -
807
2025
- -
- -
913

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
2.29
2024
- -
- -
2.13
2025
- -
- -
2.35

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.5
2024
- -
- -
0.6
2025
- -
- -
0.65

Company Description

CEO
Willy Siret
Full Time Employees
10,367
Sector
Health services
Industry
Hospital/Nursing management
Address
7 Boulevard Auguste Priou Vertou PL France 44120
IPO Date
Jun 7, 2006
Business
LNA Santé S.A. operates as a comprehensive healthcare provider specializing in the care of vulnerable individuals losing independence, managing over 85 establishments across France and Belgium with approximately 9,000 professionals. The company delivers a broad range of services including medical care and rehabilitation (SMR) facilities covering eight specializations such as respiratory assistance, cancerology, diabetology, pain management, neurological and orthopedic rehabilitation, and palliative care; nursing homes (EHPAD) and residential care homes (MRPA/MRS) for dependent elderly with dedicated Alzheimer’s units; hospital-at-home (HAD) services offering complex treatments like chemotherapy, intravenous infusions, blood transfusions, and post-operative care; surgical clinics providing general, orthopedic, ENT, urological, vascular, visceral, and cosmetic procedures; mental health clinics equipped for acute psychiatric care including electroconvulsive therapy and rTMS; and health centers with therapeutic education and psychosocial support, all supported by innovative platforms like Lokomat robotics, virtual reality, and balneotherapy. Founded in 1990 and headquartered in Vertou near Nantes, France, LNA Santé maintains a family-owned model emphasizing human-scale living units, full medical teams, and ethical drug-free therapies. Recent developments include the launch of two new hospital-at-home platforms in Caen and Rouen in 2025 to bolster growth; plans for targeted acquisitions of new establishments expected in late 2025 or early 2026 to expand geographical coverage; attainment of entreprise à mission status in 2023 under the Growing Together 3 strategic plan running through 2028, focusing on territorial development in France, Belgium, and Poland; and sustained organic revenue growth of around 9% in the first half of 2025 driven by high occupancy and specialist healthcare expansion.